This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sanders, K. M. Articles by Murray, G. B. Search for Related Content PubMed Articles by Sanders, K. M. Articles by Murray, G. B. Social Bookmarking                         What's this?

Low Incidence of Extrapyramidal Symptoms in Treatment of Delirium with Intravenous Haloperidol and Lorazepam in the Intensive Care Unit

Psychiatric Consultation Service, Massachusetts General Hospital, Boston, MA

Ann Mary Minnema

Department of Internal Medicine and Psychiatry, Blodgett Memorial Hospital, Grand Rapids, MI

George B. Murray

Psychiatric Consultation Service, Massachusetts General Hospital, Boston, MA

We retrospectively reviewed 11 patients in an intensive care unit who were treated for delirium with intrave nously administered haloperidol and lorazepam. The cu mulative doses for each episode of delirium ranged from 25.5 to 1,929 mg of haloperidol and 19.5 to 2,274 mg of lorazepam. Neuroleptic-induced rigidity developed in 1 patient. After administration of the neuroleptic was dis continued, there were no residual extrapyramidal symp toms.

Journal of Intensive Care Medicine, Vol. 4, No. 5, 201-204 (1989)
DOI: 10.1177/088506668900400504


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?